Search results for MED1 Antibody

Anti-TRAP220/MED1 antibody [BLR037F], Abcam, AB243893

REACH authorisation Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances. It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses. This product is sold under License from Bethyl Laboratories, Inc.

Mediator Complex Subunit 1 (MED1) Antibody, Abbexa, abx001441

MED1 Antibody is a Rabbit Polyclonal antibody against MED1. The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. It also regulates p53-dependent apoptosis and it is essential for adipogenesis. This protein is known to have the ability to self-oligomerize. [provided by RefSeq, Jul 2008].

Mediator Complex Subunit 1 (MED1) Antibody, Abbexa, abx325791

MED1 Antibody is a Rabbit Polyclonal against MED1.

Mediator Complex Subunit 1 (MED1) Antibody, Abbexa, abx313371

MED1 Antibody is a Rabbit Polyclonal against MED1.

Mediator Complex Subunit 1 (MED1) Antibody, Abbexa, abx013626

Rabbit polyclonal antibody against MED1 protein. Immunogen region is Internal.

Anti-TRAP220/MED1 antibody [EPR24656-87], Abcam, AB313323

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Mediator Complex Subunit 1 (MED1) Antibody, Abbexa, abx131491

MED1 Antibody is a Rabbit Polyclonal against Mediator Complex Subunit 1.

Anti-MBD4/MED1 antibody - C-terminal, Abcam, AB191037

Anti-MBD4/MED1 antibody [EPR28263-16], Abcam, AB315462

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Mediator Complex Subunit 1 (MED1) Antibody, Abbexa, abx325670

MED1 Antibody is a Rabbit Polyclonal against MED1.